Media Summary: In this segment, Raoul Tibes, MD, PhD, discusses risk stratification based on minimal residual disease Selina Luger, MD, University of Pennsylvania, Philadelphia, PA, talks about the importance of minimal residual disease ( A discussion by experts on the role of minimal residual disease (

Archive Mrd Monitoring In Acute - Detailed Analysis & Overview

In this segment, Raoul Tibes, MD, PhD, discusses risk stratification based on minimal residual disease Selina Luger, MD, University of Pennsylvania, Philadelphia, PA, talks about the importance of minimal residual disease ( A discussion by experts on the role of minimal residual disease ( ... update on the role of molecular diagnosis and measurable residual disease ( Noelle Frey, MD, from the University of Pennsylvania, Philadelphia, PA, highlights the importance of minimal residual disease ... The field of multiple myeloma (MM) has long been aware of the importance of minimal residual disease (

Gert J. Ossenkoppele, MD, PhD of VU University Medical Center, Amsterdam, Netherlands discusses his talk on the utility of ... Aaron C. Logan, MD, PhD; Bijal D. Shah, MD; and Ryan D. Cassaday, MD, consider the sensitivity and availability of current ... During the 64th American Society of Hematology (ASH) Annual Meeting and Exposition, the AML Hub was pleased to speak to ...

Photo Gallery

Archive: MRD Monitoring in Acute Myeloid Leukemia
MRD Monitoring in Acute Lymphoblastic Leukemia
Importance of MRD monitoring in ALL
Archive: AML MRD: Changing the Concept of Disease Remission
Role of MRD Testing in Adult Acute Lymphocytic Leukemia
Next-generation methodologies: the future for MRD monitoring in ALL?
Molecular diagnosis and MRD monitoring in AML
The importance of MRD assessment in all phases of ALL treatment
New MRD monitoring techniques could be most accurate predictor of relapse in MM patients
Archive: Significance of Minimal Residual Disease in Acute Myeloid Leukemia
The utility of measurable residual disease (MRD) assessment in acute myeloid leukemia (AML)
MRD Testing in ALL: Sensitivity and Availability
View Detailed Profile
Archive: MRD Monitoring in Acute Myeloid Leukemia

Archive: MRD Monitoring in Acute Myeloid Leukemia

Minimal residual disease (

MRD Monitoring in Acute Lymphoblastic Leukemia

MRD Monitoring in Acute Lymphoblastic Leukemia

In this segment, Raoul Tibes, MD, PhD, discusses risk stratification based on minimal residual disease

Importance of MRD monitoring in ALL

Importance of MRD monitoring in ALL

Selina Luger, MD, University of Pennsylvania, Philadelphia, PA, talks about the importance of minimal residual disease (

Archive: AML MRD: Changing the Concept of Disease Remission

Archive: AML MRD: Changing the Concept of Disease Remission

MRD

Role of MRD Testing in Adult Acute Lymphocytic Leukemia

Role of MRD Testing in Adult Acute Lymphocytic Leukemia

A discussion by experts on the role of minimal residual disease (

Next-generation methodologies: the future for MRD monitoring in ALL?

Next-generation methodologies: the future for MRD monitoring in ALL?

Measurable residual disease (

Molecular diagnosis and MRD monitoring in AML

Molecular diagnosis and MRD monitoring in AML

... update on the role of molecular diagnosis and measurable residual disease (

The importance of MRD assessment in all phases of ALL treatment

The importance of MRD assessment in all phases of ALL treatment

Noelle Frey, MD, from the University of Pennsylvania, Philadelphia, PA, highlights the importance of minimal residual disease ...

New MRD monitoring techniques could be most accurate predictor of relapse in MM patients

New MRD monitoring techniques could be most accurate predictor of relapse in MM patients

The field of multiple myeloma (MM) has long been aware of the importance of minimal residual disease (

Archive: Significance of Minimal Residual Disease in Acute Myeloid Leukemia

Archive: Significance of Minimal Residual Disease in Acute Myeloid Leukemia

Most patients with

The utility of measurable residual disease (MRD) assessment in acute myeloid leukemia (AML)

The utility of measurable residual disease (MRD) assessment in acute myeloid leukemia (AML)

Gert J. Ossenkoppele, MD, PhD of VU University Medical Center, Amsterdam, Netherlands discusses his talk on the utility of ...

MRD Testing in ALL: Sensitivity and Availability

MRD Testing in ALL: Sensitivity and Availability

Aaron C. Logan, MD, PhD; Bijal D. Shah, MD; and Ryan D. Cassaday, MD, consider the sensitivity and availability of current ...

How can serial MRD monitoring be utilized to improve relapse outcomes?

How can serial MRD monitoring be utilized to improve relapse outcomes?

During the 64th American Society of Hematology (ASH) Annual Meeting and Exposition, the AML Hub was pleased to speak to ...